nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—hypertension—adrenal gland cancer	0.712	1	CtDrD
Terazosin—ABCB1—adrenal gland cancer	0.269	1	CbGaD
Terazosin—KCNH6—Potassium Channels—KCNJ5—adrenal gland cancer	0.00155	0.0904	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00149	0.087	CbGpPWpGaD
Terazosin—KCNH7—Potassium Channels—KCNJ5—adrenal gland cancer	0.00138	0.0805	CbGpPWpGaD
Terazosin—KCNH6—Neuronal System—KCNJ5—adrenal gland cancer	0.000675	0.0394	CbGpPWpGaD
Terazosin—Doxazosin—ABCB1—adrenal gland cancer	0.000673	0.52	CrCbGaD
Terazosin—Prazosin—ABCB1—adrenal gland cancer	0.00062	0.479	CrCbGaD
Terazosin—KCNH7—Neuronal System—KCNJ5—adrenal gland cancer	0.000602	0.0352	CbGpPWpGaD
Terazosin—KCNH2—Potassium Channels—KCNJ5—adrenal gland cancer	0.000584	0.0341	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—GNRHR—adrenal gland cancer	0.000449	0.0263	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00034	0.0199	CbGpPWpGaD
Terazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.000303	0.0177	CbGpPWpGaD
Terazosin—KCNH6—Neuronal System—PRKACA—adrenal gland cancer	0.000259	0.0151	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—KCNJ5—adrenal gland cancer	0.000255	0.0149	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.000253	0.0148	CbGpPWpGaD
Terazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.000251	0.0147	CbGpPWpGaD
Terazosin—ADRA1A—Endothelin Pathways—GNAS—adrenal gland cancer	0.000232	0.0135	CbGpPWpGaD
Terazosin—KCNH7—Neuronal System—PRKACA—adrenal gland cancer	0.000231	0.0135	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.000226	0.0132	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.000223	0.013	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00021	0.0122	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.000187	0.011	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.000186	0.0109	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.00017	0.00996	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000167	0.00977	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.000167	0.00973	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000155	0.00908	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.000151	0.00884	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.000142	0.00827	CbGpPWpGaD
Terazosin—KCNH6—Neuronal System—BRAF—adrenal gland cancer	0.000139	0.00815	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000139	0.00811	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.000135	0.00791	CbGpPWpGaD
Terazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000134	0.00782	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000127	0.00744	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.000126	0.00735	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.000126	0.00734	CbGpPWpGaD
Terazosin—KCNH7—Neuronal System—BRAF—adrenal gland cancer	0.000124	0.00726	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000123	0.00721	CbGpPWpGaD
Terazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.000116	0.00678	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.000112	0.00656	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.000112	0.00652	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000106	0.00618	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0001	0.00586	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	9.98e-05	0.00583	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—PRKACA—adrenal gland cancer	9.76e-05	0.00571	CbGpPWpGaD
Terazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	9.63e-05	0.00563	CbGpPWpGaD
Terazosin—ADRA1D—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	9.41e-05	0.0055	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—GNRHR—adrenal gland cancer	9.39e-05	0.00549	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	8.93e-05	0.00522	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	8.91e-05	0.00521	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	8.56e-05	0.005	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	8.32e-05	0.00486	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	8.29e-05	0.00484	CbGpPWpGaD
Terazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	7.81e-05	0.00456	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—TP53—adrenal gland cancer	7.76e-05	0.00454	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—GNRH1—adrenal gland cancer	7.63e-05	0.00446	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	7.41e-05	0.00433	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	7.39e-05	0.00432	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GNRHR—adrenal gland cancer	7.2e-05	0.00421	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	7.18e-05	0.00419	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	6.94e-05	0.00405	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—TSHR—adrenal gland cancer	6.8e-05	0.00397	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	6.58e-05	0.00385	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GNRHR—adrenal gland cancer	6.54e-05	0.00382	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—GNRH1—adrenal gland cancer	6.33e-05	0.0037	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	6.05e-05	0.00354	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	5.97e-05	0.00349	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—EGFR—adrenal gland cancer	5.84e-05	0.00342	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—TSHR—adrenal gland cancer	5.64e-05	0.0033	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—GNRH1—adrenal gland cancer	5.63e-05	0.00329	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GNRHR—adrenal gland cancer	5.42e-05	0.00317	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	5.31e-05	0.0031	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—BRAF—adrenal gland cancer	5.26e-05	0.00307	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	5.12e-05	0.00299	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	5.01e-05	0.00293	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	4.82e-05	0.00282	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—TP53—adrenal gland cancer	4.62e-05	0.0027	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.31e-05	0.00252	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	4.1e-05	0.0024	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—GNAS—adrenal gland cancer	3.96e-05	0.00231	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GNRH1—adrenal gland cancer	3.92e-05	0.00229	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GNRHR—adrenal gland cancer	3.86e-05	0.00226	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—TSHR—adrenal gland cancer	3.84e-05	0.00225	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.59e-05	0.0021	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.58e-05	0.00209	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.5e-05	0.00204	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TSHR—adrenal gland cancer	3.49e-05	0.00204	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ZNRF3—adrenal gland cancer	3.37e-05	0.00197	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—GNAS—adrenal gland cancer	3.28e-05	0.00192	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GNRH1—adrenal gland cancer	3.25e-05	0.0019	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNRHR—adrenal gland cancer	3.2e-05	0.00187	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—TSHR—adrenal gland cancer	3.19e-05	0.00186	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.18e-05	0.00186	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.98e-05	0.00174	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	2.92e-05	0.0017	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.9e-05	0.0017	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TSHR—adrenal gland cancer	2.9e-05	0.00169	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	2.89e-05	0.00169	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	2.85e-05	0.00166	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	2.83e-05	0.00166	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ZNRF3—adrenal gland cancer	2.8e-05	0.00164	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	2.67e-05	0.00156	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	2.67e-05	0.00156	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—POMC—adrenal gland cancer	2.66e-05	0.00156	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.65e-05	0.00155	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.58e-05	0.00151	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	2.57e-05	0.0015	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PRKACA—adrenal gland cancer	2.5e-05	0.00146	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	2.49e-05	0.00145	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.39e-05	0.0014	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CDC42—adrenal gland cancer	2.34e-05	0.00137	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GNRH1—adrenal gland cancer	2.31e-05	0.00135	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GNAS—adrenal gland cancer	2.24e-05	0.00131	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	2.22e-05	0.0013	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	2.21e-05	0.00129	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CDC42—adrenal gland cancer	2.12e-05	0.00124	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SPRY2—adrenal gland cancer	2.12e-05	0.00124	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	2.08e-05	0.00121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TSHR—adrenal gland cancer	2.06e-05	0.0012	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GNAS—adrenal gland cancer	2.03e-05	0.00119	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	1.97e-05	0.00115	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	1.96e-05	0.00115	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.96e-05	0.00115	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	1.94e-05	0.00113	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	1.94e-05	0.00113	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	1.92e-05	0.00112	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	1.86e-05	0.00108	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	1.85e-05	0.00108	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.79e-05	0.00105	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	1.76e-05	0.00103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	1.76e-05	0.00103	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.76e-05	0.00103	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	1.72e-05	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	1.71e-05	0.001	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	1.71e-05	0.000997	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	1.68e-05	0.000985	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	1.65e-05	0.000963	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	1.61e-05	0.00094	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	1.57e-05	0.000915	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	1.56e-05	0.000912	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.54e-05	0.000901	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.54e-05	0.000901	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	1.52e-05	0.000888	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	1.51e-05	0.00088	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	1.5e-05	0.000875	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	1.48e-05	0.000865	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.45e-05	0.000848	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	1.43e-05	0.000835	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.39e-05	0.000813	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	1.37e-05	0.000799	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	1.26e-05	0.000733	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	1.25e-05	0.00073	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	1.23e-05	0.000718	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	1.21e-05	0.000707	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	1.2e-05	0.000701	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	1.17e-05	0.000684	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.17e-05	0.000682	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MED12—adrenal gland cancer	1.15e-05	0.000671	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	1.13e-05	0.000663	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	1.11e-05	0.000649	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	1.09e-05	0.000638	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	1.04e-05	0.000609	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	1.01e-05	0.000589	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	1.01e-05	0.000588	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	1e-05	0.000587	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	9.95e-06	0.000582	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	9.71e-06	0.000567	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	9.25e-06	0.000541	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	8.92e-06	0.000521	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	8.84e-06	0.000517	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	8.76e-06	0.000512	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	8.62e-06	0.000504	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PRKACA—adrenal gland cancer	8.38e-06	0.00049	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	8.36e-06	0.000488	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	8.07e-06	0.000472	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	7.97e-06	0.000466	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	7.73e-06	0.000452	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	7.42e-06	0.000434	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	7.27e-06	0.000425	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GNAS—adrenal gland cancer	6.79e-06	0.000397	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	6.7e-06	0.000392	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	6.62e-06	0.000387	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	6.46e-06	0.000377	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	6.41e-06	0.000375	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	5.95e-06	0.000348	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	5.88e-06	0.000344	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	5.76e-06	0.000337	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	5.7e-06	0.000333	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	4.78e-06	0.00028	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—adrenal gland cancer	4.57e-06	0.000267	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	4.57e-06	0.000267	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.25e-06	0.000248	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	3.83e-06	0.000224	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	3.79e-06	0.000221	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.65e-06	0.000213	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	3.37e-06	0.000197	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	3.18e-06	0.000186	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	2.83e-06	0.000165	CbGpPWpGaD
